JP2013532469A5 - - Google Patents

Download PDF

Info

Publication number
JP2013532469A5
JP2013532469A5 JP2013519790A JP2013519790A JP2013532469A5 JP 2013532469 A5 JP2013532469 A5 JP 2013532469A5 JP 2013519790 A JP2013519790 A JP 2013519790A JP 2013519790 A JP2013519790 A JP 2013519790A JP 2013532469 A5 JP2013532469 A5 JP 2013532469A5
Authority
JP
Japan
Prior art keywords
cells
cell
population
medium
hematopoietic stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013519790A
Other languages
English (en)
Japanese (ja)
Other versions
JP5996533B2 (ja
JP2013532469A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/043831 external-priority patent/WO2012009422A1/fr
Publication of JP2013532469A publication Critical patent/JP2013532469A/ja
Publication of JP2013532469A5 publication Critical patent/JP2013532469A5/ja
Application granted granted Critical
Publication of JP5996533B2 publication Critical patent/JP5996533B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013519790A 2010-07-13 2011-07-13 ナチュラルキラー細胞を生成させる方法 Active JP5996533B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36398110P 2010-07-13 2010-07-13
US61/363,981 2010-07-13
US201161497897P 2011-06-16 2011-06-16
US61/497,897 2011-06-16
PCT/US2011/043831 WO2012009422A1 (fr) 2010-07-13 2011-07-13 Procédés de génération de cellules tueuses naturelles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016133008A Division JP2017006129A (ja) 2010-07-13 2016-07-05 ナチュラルキラー細胞を生成させる方法

Publications (3)

Publication Number Publication Date
JP2013532469A JP2013532469A (ja) 2013-08-19
JP2013532469A5 true JP2013532469A5 (fr) 2014-08-28
JP5996533B2 JP5996533B2 (ja) 2016-09-21

Family

ID=44546146

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2013519790A Active JP5996533B2 (ja) 2010-07-13 2011-07-13 ナチュラルキラー細胞を生成させる方法
JP2016133008A Pending JP2017006129A (ja) 2010-07-13 2016-07-05 ナチュラルキラー細胞を生成させる方法
JP2018006034A Pending JP2018099122A (ja) 2010-07-13 2018-01-18 ナチュラルキラー細胞を生成させる方法
JP2020014338A Withdrawn JP2020096607A (ja) 2010-07-13 2020-01-31 ナチュラルキラー細胞を生成させる方法
JP2022021708A Pending JP2022078099A (ja) 2010-07-13 2022-02-16 ナチュラルキラー細胞を生成させる方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2016133008A Pending JP2017006129A (ja) 2010-07-13 2016-07-05 ナチュラルキラー細胞を生成させる方法
JP2018006034A Pending JP2018099122A (ja) 2010-07-13 2018-01-18 ナチュラルキラー細胞を生成させる方法
JP2020014338A Withdrawn JP2020096607A (ja) 2010-07-13 2020-01-31 ナチュラルキラー細胞を生成させる方法
JP2022021708A Pending JP2022078099A (ja) 2010-07-13 2022-02-16 ナチュラルキラー細胞を生成させる方法

Country Status (13)

Country Link
US (5) US8926964B2 (fr)
EP (2) EP2593542B1 (fr)
JP (5) JP5996533B2 (fr)
KR (7) KR20210063457A (fr)
CN (3) CN107828727A (fr)
AU (1) AU2011279201B2 (fr)
BR (1) BR112013000822B1 (fr)
CA (1) CA2804750C (fr)
ES (1) ES2666746T3 (fr)
IL (2) IL224204B (fr)
MX (1) MX342995B (fr)
NZ (2) NZ703888A (fr)
WO (1) WO2012009422A1 (fr)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2522890T3 (es) * 2000-12-06 2014-11-19 Anthrogenesis Corporation Método para recolectar células troncales placentarias
MX352687B (es) 2001-02-14 2017-12-04 Anthrogenesis Corp Placenta de mamiferos postparto, su uso y celulas madres placentales extraidas de ella.
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
CN103525758B (zh) 2005-12-29 2018-02-13 人类起源公司 胎盘干细胞群
EP2420567A3 (fr) 2006-10-23 2015-09-30 Anthrogenesis Corporation Procédés et compositions pour le traitement de défauts osseux avec des populations de cellules placentaires
KR20090109127A (ko) * 2007-02-12 2009-10-19 안트로제네시스 코포레이션 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 cd34+, cd45- 태반 줄기세포가 농축된 세포군
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
AU2008307633C1 (en) 2007-09-28 2015-04-30 Celularity Inc. Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
EP3539380A3 (fr) 2008-08-20 2019-12-18 Celularity, Inc. Composition améliorée de cellules et son procédé de fabrication
US8728805B2 (en) 2008-08-22 2014-05-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
EP3190179A1 (fr) * 2009-07-02 2017-07-12 Anthrogenesis Corporation Procédé de production d'érythrocytes sans cellules nourricières
CA2787992A1 (fr) 2010-01-26 2011-08-04 Anthrogenesis Corporation Traitement de cancers associes aux os utilisant des cellules souches placentaires
WO2011127117A1 (fr) 2010-04-07 2011-10-13 Anthrogenesis Corporation Angiogenèse employant des cellules souches placentaires
CA2795401A1 (fr) 2010-04-08 2011-10-13 Anthrogenesis Corporation Traitement de la sarcoidose au moyen de cellules souches du sang placentaire
KR20210063457A (ko) 2010-07-13 2021-06-01 안트로제네시스 코포레이션 천연 킬러 세포의 생성 방법
EP2658557A1 (fr) 2010-12-31 2013-11-06 Anthrogenesis Corporation Amélioration de l'efficacité de cellules souches placentaires sous l'effet de molécules d'arn modulateur
EP3443968A1 (fr) 2011-06-01 2019-02-20 Celularity, Inc. Traitement de la douleur à l'aide de cellules souches placentaires
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
US9086343B2 (en) * 2012-03-09 2015-07-21 Hitachi High-Technologies Corporation Methods for observing samples and preprocessing thereof
CN103372029A (zh) * 2012-04-19 2013-10-30 孙勇 肿瘤治疗用nk细胞新技术
EP3722416A1 (fr) * 2012-08-13 2020-10-14 Celularity, Inc. Cellules tueuses naturelles et leurs utilisations
CN102994449A (zh) * 2012-12-13 2013-03-27 上海柯莱逊生物技术有限公司 一种体外扩增nk细胞的方法
AU2013204922B2 (en) 2012-12-20 2015-05-14 Celgene Corporation Chimeric antigen receptors
EP2948544A4 (fr) 2013-01-28 2016-08-03 St Jude Childrens Res Hospital Récepteur chimérique à spécificité nkg2d adapté pour être utilisé en thérapie cellulaire contre le cancer et les maladies infectieuses
EP3622960A1 (fr) 2013-02-05 2020-03-18 Celularity, Inc. Cellules tueuses naturelles placentaires
JP5511039B1 (ja) * 2013-05-22 2014-06-04 国立大学法人九州大学 Nk細胞の調製方法
JP2016537362A (ja) * 2013-11-15 2016-12-01 アントフロゲネシス コーポレーション ヒト胎盤灌流液細胞、その亜集団を含む組成物、およびそれらの使用
JP6775426B2 (ja) * 2014-03-07 2020-10-28 エメルセル エスエーエス 臍帯血由来のプールnk細胞並びにがん及び慢性感染症の治療のためのこれらの用途
US10428305B2 (en) 2014-05-15 2019-10-01 National University Of Singapore Modified natural killer cells that express IL15 and uses thereof
CN105219710B (zh) * 2014-06-05 2020-01-10 上海厚超生物科技有限公司 一种高杀伤活性的免疫细胞群的培养方法
EP3750993B1 (fr) 2014-07-11 2023-12-27 Celgene Corporation Procédés d'amélioration de l'efficacité de la transduction de vecteurs dans des lymphocytes t
US20180008637A1 (en) * 2014-12-31 2018-01-11 Anthrogenesis Corporation Natural killer cells and uses thereof
WO2016122014A1 (fr) * 2015-01-27 2016-08-04 한국생명공학연구원 Procédé de production en masse de cellules tueuses naturelles et utilisation de cellules tueuses naturelles obtenues par le procédé en tant qu'agent anticancéreux
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途
CN105154400B (zh) * 2015-09-30 2021-02-02 中国人民解放军第三0二医院 多克隆抗乙肝病毒免疫细胞的扩增方法
US10975149B2 (en) 2015-12-16 2021-04-13 The Walter And Eliza Hall Institute Of Medical Research Inhibition of cytokine-induced SH2 protein in NK cells
CN108934158B (zh) * 2016-02-01 2022-11-15 Gc细胞治疗 细胞冻存用培养基组合物及其应用
CN107267454A (zh) * 2016-04-07 2017-10-20 北京京蒙高科干细胞技术有限公司 一种脐血nk细胞的体外扩增方法及其试剂盒与应用
CN105886470A (zh) * 2016-06-27 2016-08-24 江苏蒙彼利生物科技有限公司 一种扩增nk细胞的方法
US11525119B2 (en) 2016-09-06 2022-12-13 The Children's Medical Center Corporation Immune cells derived from induced pluripotent stem cell
AU2018234827B2 (en) 2017-03-15 2024-04-04 Orca Biosystems Inc. Compositions and methods for hematopoietic stem cell transplants
JP7270253B2 (ja) 2017-03-27 2023-05-10 ナショナル ユニヴァーシティ オブ シンガポール ナチュラルキラー細胞のエクスビボ拡大及び活性化のための刺激細胞株
EP3601532A1 (fr) * 2017-03-27 2020-02-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Nouveau procédé d'obtention de progéniteurs lymphoïdes
MX2019011514A (es) 2017-03-27 2020-01-27 Nat Univ Singapore Receptores quimericos nkg2d truncados y usos de los mismos en inmunoterapia con celulas asesinas naturales.
KR101960410B1 (ko) 2017-07-08 2019-03-20 허갑용 염화코발트로 유도된 저산소 환경을 이용한 융합효율이 높은 전이암 하이브리드 세포의 제조방법
WO2019046815A1 (fr) * 2017-08-31 2019-03-07 Poseida Therapeutics, Inc. Système de transposon et procédés d'utilisation
US20200246393A1 (en) 2017-09-28 2020-08-06 Celularity, Inc. Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
CN109593711A (zh) 2017-10-02 2019-04-09 盖米达细胞有限公司 扩增自然杀手细胞部份的扩增方法及用途
CN108220237B (zh) * 2017-12-20 2020-11-06 中国科学院遗传与发育生物学研究所 一种人的nk/t细胞系
SG11202007221QA (en) 2018-02-01 2020-08-28 Nkmax Co Ltd Method of producing natural killer cells and composition for treating cancer
CN108486054B (zh) * 2018-04-12 2022-04-19 平安爱普德(北京)生物技术有限公司 一种体外扩增i型天然细胞毒性淋巴细胞ilc1/nk的方法
US20210145883A1 (en) * 2018-05-11 2021-05-20 The Regents Of The University Of California Modification of Immune Cells to Increase Activity
WO2019231243A1 (fr) * 2018-05-29 2019-12-05 사회복지법인 삼성생명공익재단 Cellule nourricière exprimant ox40l et procédé de culture de cellules tueuses naturelles l'utilisant
US20210267190A1 (en) * 2018-07-10 2021-09-02 Nantkwest, Inc. Cryopreservation
CN109294985B (zh) 2018-10-25 2022-02-18 江苏普瑞康生物医药科技有限公司 一种用于nk细胞体外扩增的培养基体系及nk细胞体外扩增的方法
CN109337870B (zh) * 2018-12-24 2020-07-03 广东暨德康民生物科技有限责任公司 人Vγ9Vδ2T细胞扩增方法与培养基
EP3773918A4 (fr) 2019-03-05 2022-01-05 Nkarta, Inc. Récepteurs d'antigènes chimériques anti-cd19 et leurs utilisations en immunothérapie
CN114364667A (zh) 2019-04-09 2022-04-15 紐力克斯治疗公司 用于Cbl-b抑制的3-取代哌啶类化合物以及Cbl-b抑制剂与癌症疫苗和/或溶瘤病毒联合的用途
MX2021013751A (es) 2019-05-17 2022-01-26 Nurix Therapeutics Inc Compuestos de ciano ciclobutilo para la inhibicion del protooncogen b de linfoma de linaje b de casitas (cbl-b) y usos de los mismos.
CA3143198A1 (fr) * 2019-06-14 2020-12-17 G Tech Bio Llc Cellules lymphocytaires activees et leurs methodes d'utilisation pour traiter le cancer et des etats infectieux
KR20220026581A (ko) 2019-06-26 2022-03-04 누릭스 테라퓨틱스 인코포레이티드 Cbl-b 억제를 위한 치환된 벤질-트리아졸 화합물, 및 이의 추가의 용도
US11453862B2 (en) 2019-07-08 2022-09-27 Immunitybio, Inc. Mononuclear cell derived NK cells
US20220249567A1 (en) * 2019-07-22 2022-08-11 Glycostem Therapeutics B.V. Low density cell culture
US20220387395A1 (en) 2019-07-30 2022-12-08 Nurix Therapeutics, Inc. Urea, amide, and substituted heteroaryl compounds for cbl-b inhibition
JP2021136883A (ja) * 2020-03-02 2021-09-16 株式会社ガイアバイオメディシン 高活性nk細胞の処理方法
US11547726B2 (en) * 2020-03-26 2023-01-10 Honed Life Sciences, Llc Enhancement of production of NK cells from stem cells
CN111500535B (zh) * 2020-04-30 2023-04-14 惠和生物技术(上海)有限公司 用于体外培养人自然杀伤细胞的方法和培养基
CN112251405A (zh) * 2020-10-15 2021-01-22 大连天星生物技术有限责任公司 一种体外高效诱导扩增nk细胞的方法
CN114460304A (zh) * 2020-11-03 2022-05-10 广州辑因医疗科技有限公司 细胞制剂、蛋白在表征造血干细胞中的用途及判定造血干细胞的方法
US11591381B2 (en) 2020-11-30 2023-02-28 Crispr Therapeutics Ag Gene-edited natural killer cells
AU2021401052A1 (en) 2020-12-18 2023-06-22 Century Therapeutics, Inc. Chimeric antigen receptor systems with adaptable receptor specificity
WO2022144632A1 (fr) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions et procédés de différenciation de cellules souches en cellules nk
AU2022219942A1 (en) * 2021-02-09 2023-08-17 Takeda Pharmaceutical Company Limited Methods and compositions for cryopreservation of immune cells
TW202245598A (zh) * 2021-02-09 2022-12-01 美商千禧製藥公司 用於冷凍及解凍哺乳動物細胞的方法及組成物
WO2022173867A1 (fr) * 2021-02-09 2022-08-18 Millennium Pharmaceuticals, Inc. Procédés et compositions de congélation et de décongélation de cellules de mammifère
AR124835A1 (es) * 2021-02-09 2023-05-10 Millennium Pharm Inc Métodos y composiciones para la crioconservación de células inmunitarias
EP4326852A1 (fr) * 2021-04-22 2024-02-28 Artec Biotech, Inc. Procédé de production de cellules hématopoïétiques à partir de cellules souches à l'aide d'organoïdes vasculaires
CN115590013A (zh) * 2021-07-07 2023-01-13 北京鼎成肽源生物技术有限公司(Cn) 一种自然杀伤细胞的冻存液、冻存方法和应用
CN113416701B (zh) * 2021-07-28 2023-05-09 新疆西部赛澳生物科技有限责任公司 一种nk细胞培养基及培养方法
CN115261318B (zh) * 2021-09-29 2024-05-28 苏州艾凯利元生物科技有限公司 产生自然杀伤细胞的方法
WO2023081813A1 (fr) 2021-11-05 2023-05-11 St. Jude Children's Research Hospital, Inc. Récepteurs cytokiniques à glissières
CN114807031A (zh) * 2022-05-13 2022-07-29 山东赛恩福干细胞工程集团有限公司 一种人外周血免疫细胞库和干细胞库的构建方法
WO2023240182A1 (fr) 2022-06-08 2023-12-14 St. Jude Children's Research Hospital, Inc. Perturbation du kdm4a dans les lymphocytes t pour améliorer l'immunothérapie
CN114736859B (zh) * 2022-06-13 2022-08-19 广东先康达生物科技有限公司 一种脐带血nk细胞的培养液及培养方法
CN115094037B (zh) * 2022-07-19 2023-11-10 百欧派(天津)生物技术有限公司 配合自体血浆使用的具有犬自然杀伤细胞体外激活功能的组合物及其用途
WO2024059787A1 (fr) 2022-09-16 2024-03-21 St. Jude Children's Research Hospital, Inc. Perturbation de l'asxl1 dans les lymphocytes t pour améliorer l'immunothérapie
WO2024077156A2 (fr) * 2022-10-05 2024-04-11 Garuda Therapeutics, Inc. Lignées de cellules tueuses naturelles dérivés de cellules pluripotentes

Family Cites Families (291)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862002A (en) 1962-05-08 1975-01-21 Sanfar Lab Inc Production of physiologically active placental substances
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
NZ226750A (en) 1987-10-29 1990-09-26 Amrad Corp Ltd Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
GB8803697D0 (en) 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5284766A (en) 1989-02-10 1994-02-08 Kao Corporation Bed material for cell culture
FR2646438B1 (fr) 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5605822A (en) 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5635386A (en) 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5763266A (en) 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
ATE423195T1 (de) 1989-07-25 2009-03-15 Cell Genesys Inc Homologe rekombination für universelle donorzellen und chimerische säugetierzellen
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
DK0452484T3 (da) 1989-11-06 1996-10-14 Cell Genesys Inc Fremstilling af proteiner ved homolog rekombination
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US6326198B1 (en) 1990-06-14 2001-12-04 Regents Of The University Of Michigan Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5190556A (en) 1991-03-19 1993-03-02 O.B. Tech, Inc. Cord cutter sampler
US5744361A (en) 1991-04-09 1998-04-28 Indiana University Expansion of human hematopoietic progenitor cells in a liquid medium
EP0552380A4 (en) 1991-08-08 1995-01-25 Kao Corp Cell culture support, production thereof, and production of cell cluster using same
EP0529751A1 (fr) 1991-08-09 1993-03-03 W.R. Grace & Co.-Conn. Support et composition d'essai pour culture cellulaire
WO1993004169A1 (fr) 1991-08-20 1993-03-04 Genpharm International, Inc. Ciblage de genes dans des cellules animales au moyen de produits de synthese d'adn isogeniques
US5356373A (en) 1991-11-15 1994-10-18 Miles Inc. Method and apparatus for autologous transfusions in premature infants
EP0627003A1 (fr) 1991-12-23 1994-12-07 British Bio-Technology Limited Proteines inhibant les cellules souches
US5668104A (en) 1992-03-31 1997-09-16 Toray Industries, Inc. Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo
US5552267A (en) 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5436151A (en) 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5672499A (en) 1992-07-27 1997-09-30 California Institute Of Technology Immoralized neural crest stem cells and methods of making
US5672346A (en) 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
AU5603894A (en) 1992-11-16 1994-06-08 Applied Immune Sciences, Inc. Pluripotential quiescent stem cell population
US5772992A (en) 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5654186A (en) 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
DE69431473T2 (de) 1993-03-31 2003-08-07 Pro Neuron Inc Inhibitor der stammzellproliferation und seine verwendung
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5372581A (en) 1993-07-21 1994-12-13 Minneapolis Children's Services Corporation Method and apparatus for placental blood collection
IL107483A0 (en) 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US6288030B1 (en) 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
US6001654A (en) 1994-01-28 1999-12-14 California Institute Of Technology Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
ES2206509T3 (es) 1994-06-06 2004-05-16 Case Western Reserve University Biomatriz para la regeneracion de tejidos.
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
DE4422667A1 (de) 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
US6103522A (en) 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
US5516532A (en) 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5827742A (en) 1994-09-01 1998-10-27 Beth Israel Deaconess Medical Center, Inc. Method of selecting pluripotent hematopioetic progenitor cells
US5665557A (en) 1994-11-14 1997-09-09 Systemix, Inc. Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
PT793714E (pt) 1994-11-16 2002-12-31 Amgen Inc Utilizacao do factor de celulas estaminais e do receptor de interleucina 6 soluvel para a expansao ex vivo de celulas hematopoieticas multipotentes
US5914268A (en) 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5789147A (en) 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US6011000A (en) 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US5716616A (en) 1995-03-28 1998-02-10 Thomas Jefferson University Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
US5733541A (en) 1995-04-21 1998-03-31 The Regent Of The University Of Michigan Hematopoietic cells: compositions and methods
US5677139A (en) 1995-04-21 1997-10-14 President And Fellows Of Harvard College In vitro differentiation of CD34+ progenitor cells into T lymphocytes
EP0822955B1 (fr) 1995-04-27 1999-03-10 The Procter & Gamble Company Substrat support traite avec une emulsion inverse a haute teneur en phase aqueuse interne constituee d'un emulsifiant d'organopolysiloxane-polyoxyalkylene
US5925567A (en) 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US5830708A (en) 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
WO1996040875A1 (fr) 1995-06-07 1996-12-19 Novartis Ag Procedes d'obtention de compositions enrichies en cellules souches hematopoietiques et anticorps utilises a cet effet
US5654381A (en) 1995-06-16 1997-08-05 Massachusetts Institute Of Technology Functionalized polyester graft copolymers
US6306575B1 (en) 1995-06-16 2001-10-23 Stemcell Technologies, Inc. Methods for preparing enriched human hematopoietic cell preparations
US5877299A (en) 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US5858782A (en) 1995-11-13 1999-01-12 Regents Of The University Of Michigan Functional human hematopoietic cells
US5922597A (en) 1995-11-14 1999-07-13 Regents Of The University Of Minnesota Ex vivo culture of stem cells
ATE288480T1 (de) 1995-11-16 2005-02-15 Univ Case Western Reserve Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
EP0861894B1 (fr) 1995-11-17 2006-03-08 Asahi Kasei Kabushiki Kaisha Polypeptide suppresseur et de differenciation
US5716794A (en) 1996-03-29 1998-02-10 Xybernaut Corporation Celiac antigen
CA2251983C (fr) 1996-04-19 2003-12-16 Sudhakar Kadiyala Regeneration et croissance osseuse obtenues a l'aide de cellules souches du mesenchyme
CA2253724A1 (fr) 1996-04-26 1997-11-06 Case Western Reserve University Regeneration de la peau au moyen des cellules souches mesenchymateuses
US5919176A (en) 1996-05-14 1999-07-06 Children's Hospital Medical Center Of Northern California Apparatus and method for collecting blood from an umbilical cord
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US5851984A (en) 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US5916202A (en) 1996-08-30 1999-06-29 Haswell; John N. Umbilical cord blood collection
US6227202B1 (en) 1996-09-03 2001-05-08 Maulana Azad Medical College Method of organogenesis and tissue regeneration/repair using surgical techniques
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
US5969105A (en) 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6231880B1 (en) 1997-05-30 2001-05-15 Susan P. Perrine Compositions and administration of compositions for the treatment of blood disorders
CA2294944A1 (fr) 1997-07-03 1999-01-14 Osiris Therapeutics, Inc. Cellules souches mesenchymateuses humaines du sang peripherique
WO1999003973A1 (fr) 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Regeneration du muscle cardiaque a l'aide de cellules souche mesenchymateuses
US7514074B2 (en) 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US6077708A (en) 1997-07-18 2000-06-20 Collins; Paul C. Method of determining progenitor cell content of a hematopoietic cell culture
US5879318A (en) 1997-08-18 1999-03-09 Npbi International B.V. Method of and closed system for collecting and processing umbilical cord blood
AU9127098A (en) 1997-09-04 1999-03-22 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6093531A (en) 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
US6248587B1 (en) 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6059968A (en) 1998-01-20 2000-05-09 Baxter International Inc. Systems for processing and storing placenta/umbilical cord blood
US6291240B1 (en) 1998-01-29 2001-09-18 Advanced Tissue Sciences, Inc. Cells or tissues with increased protein factors and methods of making and using same
EP1062321B1 (fr) 1998-03-13 2004-12-29 Osiris Therapeutics, Inc. Utilisations de cellules souches humaines mesenchymateuses non autologues
WO1999047163A2 (fr) 1998-03-18 1999-09-23 Osiris Therapeutics, Inc. Cellules de souche mesenchymateuse servant a la prevention et au traitement des reponses immunitaires lors de la transplantation
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
AU2999199A (en) 1998-04-03 1999-10-25 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
EP1075266A1 (fr) 1998-05-04 2001-02-14 Point Therapeutics, Inc. Stimulation hematopoietique
US6835377B2 (en) 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
WO1999061588A1 (fr) 1998-05-22 1999-12-02 Osiris Therapeutics, Inc. Production de megacaryocytes par co-culture de cellules souches mesenchymateuses humaines au moyen de cellules cd34+
DK1082410T3 (da) 1998-05-29 2007-11-26 Osiris Therapeutics Inc Humane CD45 - og/eller fibroblast mesenchymale stamceller
WO1999064566A2 (fr) 1998-06-08 1999-12-16 Osiris Therapeutics, Inc. Conservation in vitro de cellules souches hematopoïetiques
DK1084230T3 (da) 1998-06-08 2008-03-03 Osiris Therapeutics Inc Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller
US6713245B2 (en) 1998-07-06 2004-03-30 Diacrin, Inc. Methods for storing neural cells such that they are suitable for transplantation
PT1100488E (pt) 1998-07-28 2003-09-30 Synthes Ag Utilizacao de compostos de creatina para tratamento das celulas e tecidos do osso ou cartilagem
US5958767A (en) 1998-08-14 1999-09-28 The Children's Medical Center Corp. Engraftable human neural stem cells
JP3517359B2 (ja) 1998-09-14 2004-04-12 テルモ株式会社 細胞分離・回収装置および細胞の分離・回収方法
CA2345397A1 (fr) 1998-09-23 2000-03-30 Mount Sinai Hospital Preparations de cellules trophoblastiques
EP1129176A4 (fr) 1998-11-09 2002-10-30 Es Cell Int Pte Ltd Cellules souches embryonnaires
CN1180079C (zh) 1998-11-12 2004-12-15 基质细胞有限责任公司 在三维装置中从造血祖细胞产生淋巴组织-特异细胞
US6548299B1 (en) 1999-11-12 2003-04-15 Mark J. Pykett Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
US6184035B1 (en) 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
US6102871A (en) 1998-11-23 2000-08-15 Coe; Rosemarie O. Blood collection funnel
US6328765B1 (en) 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
US6733433B1 (en) 1998-12-24 2004-05-11 Biosafe S.A. Blood separation system particularly for concentrating hematopoietic stem cells
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
IN191359B (fr) 1999-04-20 2003-11-29 Nat Inst Immunology
WO2000073421A2 (fr) 1999-06-02 2000-12-07 Lifebank Services, L.L.C. Methodes d'isolement, de cryopreservation, et d'utilisation therapeutique de cellules epitheliales amniotiques humaines
US6333029B1 (en) 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US6239157B1 (en) 1999-09-10 2001-05-29 Osiris Therapeutics, Inc. Inhibition of osteoclastogenesis
US6685936B2 (en) 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
DE19954421A1 (de) 1999-11-12 2001-05-31 Lohmann Therapie Syst Lts Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
US7405078B2 (en) 2000-03-16 2008-07-29 Cellseed Inc. Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom
US20010038836A1 (en) 2000-04-04 2001-11-08 Matthew During Application of myeloid-origin cells to the nervous system
ES2267778T3 (es) 2000-06-06 2007-03-16 Glaxo Group Limited Composicion para el tratamiento del cancer, que contiene un agente anti-neoplastico y un inhibidor de pde4.
US20050009876A1 (en) 2000-07-31 2005-01-13 Bhagwat Shripad S. Indazole compounds, compositions thereof and methods of treatment therewith
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
ES2522890T3 (es) 2000-12-06 2014-11-19 Anthrogenesis Corporation Método para recolectar células troncales placentarias
US20080152629A1 (en) 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
US7091353B2 (en) 2000-12-27 2006-08-15 Celgene Corporation Isoindole-imide compounds, compositions, and uses thereof
US20030045552A1 (en) 2000-12-27 2003-03-06 Robarge Michael J. Isoindole-imide compounds, compositions, and uses thereof
EP1491093B1 (fr) 2001-02-14 2013-07-31 ABT Holding Company Cellules souches adultes multipotentes, sources de ces cellules, procédés d'obtention et de maintien de ces dernières, procédés de différentiation de ces cellules, procédés d'utilisation correspondants et cellules dérivées des cellules susmentionnées
MXPA03007175A (es) 2001-02-14 2005-02-14 Anthrogenesis Corp Placenta de mamiferos postparto, su uso y celulas madres placentales extraidas de ella.
MX352687B (es) 2001-02-14 2017-12-04 Anthrogenesis Corp Placenta de mamiferos postparto, su uso y celulas madres placentales extraidas de ella.
US20020132343A1 (en) 2001-03-19 2002-09-19 Clark Lum System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
CA2396536A1 (fr) 2001-08-10 2003-02-10 Saiko Uchida Cellules souches dumaines provenant de la couche de cellules mesenchymateuses de l'amnios humain
DE10139783C1 (de) 2001-08-14 2003-04-17 Transtissue Technologies Gmbh Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung
US20030044976A1 (en) 2001-08-27 2003-03-06 Advanced Cell Technology De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
EP1288293A1 (fr) 2001-08-30 2003-03-05 Norio Sakuragawa Cellules souches neuronales humaines originaires d'une couche de cellules mesenchymateuses amniotiques humaines
CN1195055C (zh) 2001-09-06 2005-03-30 周胜利 从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
US20030068306A1 (en) 2001-09-14 2003-04-10 Dilber Mehmet Sirac Medium
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
AU2002363659B2 (en) 2001-11-15 2008-09-25 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
JP3728750B2 (ja) 2001-11-22 2005-12-21 ニプロ株式会社 培養皮膚及びその製造方法
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
JP3934539B2 (ja) 2001-12-12 2007-06-20 独立行政法人科学技術振興機構 胎盤等由来の成体又は生後組織の前駆細胞
AU2003205266A1 (en) 2002-01-22 2003-09-02 Advanced Cell Technology, Inc. Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis
WO2003068937A2 (fr) 2002-02-13 2003-08-21 Anthrogenesis Corporation Cellules souches de type embryonnaire derivees de placenta mammalien post-partum, utilisations, et procedes de traitement a base de cellules de ce type
US20030161818A1 (en) 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
AU2003267949A1 (en) 2002-03-15 2003-12-31 U.S. Government As Represented By The Department Of Veterans Affairs Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
EP1538913A2 (fr) 2002-04-12 2005-06-15 Celgene Corporation Modulation de differenciation de cellule souche et de cellule progenitrice, analyses et utilisations associees
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1496878A4 (fr) 2002-04-12 2007-12-26 Celgene Corp Techniques d'identification de modulateurs d'angiogenese, composes decouverts par ces techniques et techniques de traitement utilisant ces composes
US20030235563A1 (en) 2002-04-19 2003-12-25 Strom Stephen C. Placental derived stem cells and uses thereof
US20040161419A1 (en) 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
CA2488013A1 (fr) 2002-05-30 2003-12-11 Celgene Corporation Procedes d'utilisation d'inhibiteurs de jnk ou de mkk en vue de moduler la differenciation cellulaire et de traiter des troubles myeloproliferatifs et des syndromes myelodysplasiques
US7422736B2 (en) 2002-07-26 2008-09-09 Food Industry Research And Development Institute Somatic pluripotent cells
WO2004013275A2 (fr) 2002-07-31 2004-02-12 Yves Saint-Laurent Parfums Cellules souches issues de tissu adipeux et cellules differenciees issues de ces cellules
WO2004018658A1 (fr) 2002-08-23 2004-03-04 Srl, Inc. Cellules souches d'os humains
US20040062753A1 (en) 2002-09-27 2004-04-01 Alireza Rezania Composite scaffolds seeded with mammalian cells
CN1717177A (zh) 2002-11-26 2006-01-04 人类起源公司 细胞治疗剂、细胞治疗单元及其用于治疗的方法
CA2515469C (fr) 2003-02-11 2013-12-17 John E. Davies Cellules progenitrices provenant de la gelee de wharton de cordon ombilical humain
NZ542127A (en) 2003-02-13 2008-04-30 Anthrogenesis Corp Use of umbilical cord blood to treat individuals having a disease, disorder or condition
WO2004087896A2 (fr) 2003-03-31 2004-10-14 Pfizer Products Inc. Mise en croissance et differenciation de cellules souches
CN1548529A (zh) 2003-05-09 2004-11-24 中国人民解放军军事医学科学院基础医 一种人胎盘间充质干细胞的分离方法
PL2338982T3 (pl) 2003-06-27 2016-01-29 Depuy Synthes Products Inc Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US7569385B2 (en) 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
US20050089513A1 (en) 2003-10-28 2005-04-28 Norio Sakuragawa Side population cells originated from human amnion and their uses
WO2005047491A2 (fr) 2003-11-10 2005-05-26 Amgen Inc. Methodes d'utilisation de cellules de c-kit+ mobilisees par g-cff pour produire des grappes de cellules semblables a un corps embryoide pour la reparation tissulaire et le traitement de la myopathie cardiaque
KR100560340B1 (ko) 2003-11-11 2006-03-14 한훈 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법
JP2005151907A (ja) 2003-11-27 2005-06-16 Shigeo Saito 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法
NZ548049A (en) 2003-12-02 2009-01-31 Celgene Corp Methods and compositions for the treatment and management of hemoglobinopathy and anemia
TWI338714B (en) 2003-12-02 2011-03-11 Cathay General Hospital Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
US20050176139A1 (en) 2004-01-12 2005-08-11 Yao-Chang Chen Placental stem cell and methods thereof
US20050266391A1 (en) 2004-01-15 2005-12-01 Bennett Brydon L Methods for preserving tissue
EP2298862B1 (fr) 2004-03-22 2017-08-30 Mesoblast International Sàrl Cellules souches mésenchymateuses et utilisations associées
EP2312482A1 (fr) 2004-03-26 2011-04-20 Celgene Corporation Systèmes et procédés pour produire une banque de cellules souches
WO2005105982A1 (fr) 2004-03-31 2005-11-10 Reinhardt Schwartz-Albiez Procede pour realiser l'expansion sequentielle ex vivo de cellules souches post-embryonnaires humaines, suivie d'une differenciation selective
WO2005105992A1 (fr) 2004-04-21 2005-11-10 New York Eye & Ear Infirmary Formulations de culture de chondrocytes
WO2006004592A2 (fr) * 2004-05-28 2006-01-12 Mayo Foundation For Medical Education And Research Methodes pour une transplantation de cellules souches autologues
JP2006006249A (ja) 2004-06-28 2006-01-12 Hiroshima Univ 羊膜由来細胞の培養方法及びその利用
US7244759B2 (en) 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
WO2006015214A2 (fr) 2004-07-29 2006-02-09 Steenblock Research Institute, Inc. Composition de cellules souches de cordon ombilical et methode de traitement de maladies neurologiques
EP1789534B1 (fr) 2004-08-16 2014-08-06 CellResearch Corporation Pte Ltd Isolement de cellules souches/progenitrices issues de la membrane amniotique du cordon ombilical
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
US7909806B2 (en) 2004-09-23 2011-03-22 Anthrogenesis Corporation Cord blood and placenta collection kit
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20060171930A1 (en) 2004-12-21 2006-08-03 Agnieszka Seyda Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
WO2006083394A2 (fr) 2004-12-21 2006-08-10 Ethicon, Inc. Cellules post-partum derivees de tissu placentaire et leurs procedes de production, de culture et d'utilisation
JP5340599B2 (ja) 2004-12-23 2013-11-13 エシコン・インコーポレイテッド 臍帯組織由来産褥細胞ならびにその製造方法および使用方法
PT1835924E (pt) 2004-12-23 2013-11-19 Ethicon Inc Tratamento da doença de parkinson e desordens relacionadas usando células derivadas do pós-parto
US9056093B2 (en) 2005-01-07 2015-06-16 Wake Forest University Health Sciences Regeneration of pancreatic islets by amniotic fluid stem cell therapy
WO2006091766A2 (fr) 2005-02-24 2006-08-31 Jau-Nan Lee Cellules souches du trophoblaste humain et utilisation associee
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
WO2006111706A1 (fr) 2005-04-16 2006-10-26 Axordia Limited Cellule souche decytotrophoblaste
AU2006202209B2 (en) 2005-05-27 2011-04-14 Lifescan, Inc. Amniotic fluid derived cells
NZ564563A (en) 2005-06-10 2011-03-31 Celgene Corp Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions
US20070038298A1 (en) 2005-06-30 2007-02-15 Sulner Joseph W Repair of tympanic membrane using placenta derived collagen biofabric
WO2007009062A2 (fr) 2005-07-13 2007-01-18 Anthrogenesis Corporation Traitement d'ulceres de la jambe a l'aide d'un tissu biologique a base de collagene derive de placenta
EP1919365A2 (fr) 2005-07-13 2008-05-14 Anthrogenesis Corporation Obturateur oculaire forme a partir dun tissu biologique a base de collagene derive du placenta
WO2007011693A2 (fr) 2005-07-14 2007-01-25 Medistem Laboratories, Inc. Compositions de cellules souches derivees du placenta, utilisees dans le traitement de cancers
EP1915440A4 (fr) 2005-08-19 2009-11-04 Bio Regenerate Inc Compositions cellulaires enrichies destines a la combinaison de diverses populations cellulaires a base de cellules souches et de cellules progenitrices, leurs methodes d'utilisation, et methodes de mise en banque privee
CN101258160A (zh) * 2005-09-12 2008-09-03 全南大学校产学协力团 成熟自然杀伤细胞的制备方法
EP1789435B1 (fr) * 2005-09-12 2010-02-24 Industry Foundation of Chonnam National University Methode de production de cellule tueuse naturelle mature
EP1941027B1 (fr) 2005-09-28 2014-08-20 IPD-Therapeutics B.V. Procédés et moyens pour la prolifération de cellules souches, pour la génération et le développement ultérieurs de cellules progénitrices et pour la production de cellules effectrices en tant que traitement clinique
SI1957633T1 (sl) 2005-10-13 2014-04-30 Anthrogenesis Corporation Imunomodulacija z uporabo matičnih celic iz placente
EP2368973A1 (fr) 2005-10-13 2011-09-28 Anthrogenesis Corporation Production d'oligodendrocytes a partir de cellules souches derivees du placenta
CN100344757C (zh) 2005-10-18 2007-10-24 天津昂赛细胞基因工程有限公司 人胎盘、脐带间充质干细胞库及其构建方法
CN101374946B (zh) 2005-12-16 2017-07-18 伊西康公司 用于在组织相容性不匹配的移植中抑制有害的免疫反应的组合物和方法
ES2391034T3 (es) 2005-12-19 2012-11-20 Ethicon, Inc. Expansión in vitro de células derivadas postparto en frascos rotatorios
AU2006329195B2 (en) 2005-12-22 2012-09-20 John E. Davies Viable cells from frozen umbilical cord tissue
JP5599568B2 (ja) 2005-12-28 2014-10-01 エシコン・インコーポレイテッド 分娩後由来細胞を用いた末梢血管疾患の治療
AU2006332680A1 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
CN103525758B (zh) 2005-12-29 2018-02-13 人类起源公司 胎盘干细胞群
EP2412801A1 (fr) 2005-12-29 2012-02-01 Anthrogenesis Corporation Co-culture de cellules souches de placenta et cellules souches d'une deuxième source
US20070253931A1 (en) 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
US9944900B2 (en) 2006-01-18 2018-04-17 Hemacell Perfusion Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
NZ744465A (en) 2006-01-23 2023-04-28 Abt Holding Co Mapc therapeutics without adjunctive immunosuppressive treatment
JP2009539378A (ja) 2006-06-09 2009-11-19 アントフロゲネシス コーポレーション 胎盤環境及び幹細胞を培養するためのその使用
US20070287176A1 (en) 2006-06-13 2007-12-13 Alireza Rezania Chorionic villus derived cells
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008021391A1 (fr) 2006-08-15 2008-02-21 Anthrogenesis Corporation Biomatériau à base de cordon ombilical pour usage médical
US8122763B2 (en) 2006-09-01 2012-02-28 Avair, Llc Breathing gas supply visual broadcast apparatus
US20080131522A1 (en) 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
ES2516698T3 (es) 2006-10-06 2014-10-31 Anthrogenesis Corporation Composiciones de colágeno placentario (telopéptido) nativo
EP2420567A3 (fr) 2006-10-23 2015-09-30 Anthrogenesis Corporation Procédés et compositions pour le traitement de défauts osseux avec des populations de cellules placentaires
CA2669589C (fr) 2006-11-13 2016-01-12 Ethicon, Incorporated Expansion in vitro de cellules post-natales au moyen de microporteurs
KR20090109127A (ko) 2007-02-12 2009-10-19 안트로제네시스 코포레이션 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 cd34+, cd45- 태반 줄기세포가 농축된 세포군
WO2008100498A2 (fr) 2007-02-12 2008-08-21 Anthrogenesis Corporation Traitement des maladies inflammatoires au moyen de cellules souches placentaires
WO2008118020A1 (fr) 2007-03-27 2008-10-02 Ipd-Therapeutics B.V. Procédés et moyen destiné à la prolifération des cellules souches et à la génération et à l'expansion subséquente de cellules progénitrices et production de cellules effectrices utilisées commes agents thérapeutiques cliniques
US20100172830A1 (en) 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
KR100902340B1 (ko) * 2007-08-02 2009-06-12 한국생명공학연구원 Yc-1 또는 il-21을 유효성분으로 포함하는자연살해세포 분화제 및 분화 방법
JP5703493B2 (ja) 2007-09-26 2015-04-22 アンスロジェネシス コーポレーション ヒト胎盤灌流液由来の血管形成細胞
AU2008307633C1 (en) 2007-09-28 2015-04-30 Celularity Inc. Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
KR20210056449A (ko) 2007-11-07 2021-05-18 안트로제네시스 코포레이션 조산 합병증의 치료에 있어서의 제대혈의 용도
US20090123442A1 (en) 2007-11-09 2009-05-14 Avaris Ab Expanded nk cells
EP2235162B1 (fr) * 2008-01-08 2014-10-15 The University Of Queensland Procédé de production d'une population de cellules
KR101133185B1 (ko) 2008-07-29 2012-04-06 서울대학교병원 자연살해세포의 증식방법
CA2734237C (fr) 2008-08-20 2019-07-02 Anthrogenesis Corporation Traitement d'un accident vasculaire cerebral a l'aide de cellules placentaires isolees
EP3539380A3 (fr) 2008-08-20 2019-12-18 Celularity, Inc. Composition améliorée de cellules et son procédé de fabrication
US8728805B2 (en) 2008-08-22 2014-05-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
EP2336303B1 (fr) * 2008-09-08 2015-07-15 Riken CELLULES iPS ISSUES DE CELLULES NKT ET CELLULES NKT ASSOCIEES
CN101684456A (zh) * 2008-09-28 2010-03-31 江门罗森生物制药有限公司 一种体外培养条件下扩增人nk细胞的方法
KR101077912B1 (ko) * 2008-10-24 2011-10-31 주식회사 메디셀 제대혈로부터 효율적인 자연살해세포의 증식 및 분화 방법
RU2562154C2 (ru) 2008-11-19 2015-09-10 Антродженезис Корпорейшн Амниотические адгезивные клетки
DK2375907T3 (da) 2008-11-21 2019-06-11 Celularity Inc Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller
EP2398897B1 (fr) * 2009-02-20 2017-06-28 Cellular Dynamics International, Inc. Procédés et compositions pour la différenciation de cellules souches
EP3489352A1 (fr) 2009-03-25 2019-05-29 Celularity, Inc. Élimination de tumeurs au moyen de cellules tueuses intermédiaires tirées du placenta humain et composés immunomodulateurs
CN102428173B (zh) 2009-03-26 2014-07-30 细胞维护北欧制药公司 Nk细胞的扩增
WO2010141654A1 (fr) 2009-06-05 2010-12-09 Anthrogenesis Corporation Procédé amélioré de collecte de cellules placentaires
EP3190179A1 (fr) 2009-07-02 2017-07-12 Anthrogenesis Corporation Procédé de production d'érythrocytes sans cellules nourricières
CA2787992A1 (fr) 2010-01-26 2011-08-04 Anthrogenesis Corporation Traitement de cancers associes aux os utilisant des cellules souches placentaires
US20110280849A1 (en) 2010-03-26 2011-11-17 Anthrogenesis Corporation Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
WO2011127117A1 (fr) 2010-04-07 2011-10-13 Anthrogenesis Corporation Angiogenèse employant des cellules souches placentaires
CA2795401A1 (fr) 2010-04-08 2011-10-13 Anthrogenesis Corporation Traitement de la sarcoidose au moyen de cellules souches du sang placentaire
KR20210063457A (ko) 2010-07-13 2021-06-01 안트로제네시스 코포레이션 천연 킬러 세포의 생성 방법
WO2012075412A1 (fr) 2010-12-03 2012-06-07 Michael Verneris Génération de cellules tueuses naturelles et de cellules tueuses naturelles-22 (nk22) de type inductrices de tissu lymphoïde (de type lti)
AU2011342904B2 (en) 2010-12-17 2016-05-12 Biolamina Ab Cell culture medium
MX2013007611A (es) 2010-12-30 2013-12-06 Anthrogenesis Corp Metodos para criopreservar y encapsular celulas.
WO2012092458A2 (fr) 2010-12-30 2012-07-05 Anthrogenesis Corporation Compositions contenant des cellules souches placentaires et du plasma riche en plaquettes, et leurs méthodes d'utilisation
WO2012092480A1 (fr) 2010-12-30 2012-07-05 Anthirogenesis Corporation Compositions comprenant des cellules adhérentes dérivées d'amnion et du plasma riche en plaquettes
EP2658557A1 (fr) 2010-12-31 2013-11-06 Anthrogenesis Corporation Amélioration de l'efficacité de cellules souches placentaires sous l'effet de molécules d'arn modulateur
EP3443968A1 (fr) 2011-06-01 2019-02-20 Celularity, Inc. Traitement de la douleur à l'aide de cellules souches placentaires

Similar Documents

Publication Publication Date Title
JP2013532469A5 (fr)
JP2015526088A5 (fr)
US20220259563A1 (en) Methods of generating natural killer cells
RU2015108761A (ru) Природные клетки-киллеры и их применение
Hadland et al. Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros–derived hematopoietic stem cells
Knorr et al. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy
JP2023036648A (ja) 遺伝子改変されたナチュラルキラー細胞
Cany et al. Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer
Chabannon et al. Manufacturing natural killer cells as medicinal products
JP2019528771A5 (fr)
JP2016509840A5 (fr)
Min et al. Optimization of large-scale expansion and cryopreservation of human natural killer cells for anti-tumor therapy
Burnham et al. Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
Li et al. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells
DE14740451T1 (de) Verfahren zur Herstellung einer immunozytenhaltigen Zusammensetzung und Zusammenstzung zur Behandlung von Krebs
JP2012143229A5 (fr)
Chotinantakul et al. Wnt1 accelerates an ex vivo expansion of human cord blood CD34+ CD38− cells
Radtke et al. Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice
Ukrainskaya et al. Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study
Flores-Guzmán et al. In vitro characterization of two lineage-negative CD34+ cell-enriched hematopoietic cell populations from human UC blood
RU2016104419A (ru) Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+
Molaeipour et al. The effect of bone marrow mesenchymal stem cells on vitamin D3 induced monocytic differentiation of U937 cells
Li et al. CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Giebel Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in nSG mice
Prashad Defining Self-renewal in Human Hematopoietic Stem Cells